Sangamo Therapeutics (SGMO) Revenue (2010 - 2026)
Sangamo Therapeutics (SGMO) revenue from Jun 30, 2010 to Mar 31, 2026. The TTM Sangamo Therapeutics (SGMO) revenue is $35M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Sangamo Therapeutics (SGMO) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -45.80% |
| 3 Years TTM | -47.66% |
| 5 Years TTM | -23.44% |
| 10 Years TTM | +1.43% |
| All Time TTM | +11.82% |
Annual Revenue change of Sangamo Therapeutics (SGMO)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $1.44M | -96.36% |
| 2025 | $40M | -31.57% |
| 2024 | $58M | -67.20% |
| 2023 | $176M | +58.34% |
| 2022 | $111M | +0.54% |
| 2021 | $111M | -6.34% |
| 2020 | $118M | +15.39% |
| 2019 | $102M | +21.29% |
| 2018 | $84M | +130.93% |
| 2017 | $37M | +88.60% |
| 2016 | $19M | -50.96% |
| 2015 | $40M | -13.80% |
| 2014 | $46M | +90.10% |
| 2013 | $24M | +11.40% |
| 2012 | $22M | +109.88% |
| 2011 | $10M | -50.41% |
| 2010 | $21M | -6.22% |
| 2009 | $22M | N/A |
Comparison Sangamo Therapeutics (SGMO) five years revenue CAGR with competitors
Sangamo Therapeutics (SGMO) five years revenue CAGR is -23.44%.